Sichuan Kelun Pharmaceutical Co., Ltd. Class A
002422
Rang în acțiuni
#2010
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and... Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injections. In addition, the company engages in investment; import and export; enterprise management; logistics and transportation; business services; agricultural non-staple food processing; production and sale of pharmaceutical intermediates; research and development of bio-based materials technology; Internet and related services; crop planting; professional technical; biotechnology extension; socio-economic consultation; technology promotion; medical research and testing exhibition; general cargo road transport; ecological protection and environmental management; and wholesale and retail. It exports its products to Japan. The company was formerly known as Sichuan Kelun Pharmaceutical Factory Co., Ltd and changed its name to Sichuan Kelun Pharmaceutical Co., Ltd. in August 2003. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Industry Group CO., LTD.
Preț acțiune
$6.40
Capitalizare de piață
$10.19B
Schimbare (1 zi)
-0.77%
Schimbare (1 an)
27.14%
Țară
CN
Tranzacționează Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Categorie
Healthcare
Venituri pentru Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Venituri în Jun 2026 TTM: $2.74B
Conform celor mai recente rapoarte financiare ale Sichuan Kelun Pharmaceutical Co., Ltd. Class A, venitul actual al companiei (TTM) este $2.74B. În anul 2024, compania a avut un venit de $2.99B o scădere comparativ cu venitul din anul 2023, care a fost de $3.03B. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Sichuan Kelun Pharmaceutical Co., Ltd. Class A din 2007 până în 2026
Venituri la sfârșitul fiecărui an
| An | Venituri | Schimbă |
|---|---|---|
| 2026 (TTM) | $2.74B | 4.30% |
| 2025 | $2.62B | -12.23% |
| 2024 | $2.99B | -1.40% |
| 2023 | $3.03B | 9.81% |
| 2022 | $2.76B | 1.53% |
| 2021 | $2.72B | 7.86% |
| 2020 | $2.52B | -0.49% |
| 2019 | $2.53B | 6.54% |
| 2018 | $2.38B | 35.26% |
| 2017 | $1.76B | 42.45% |
| 2016 | $1.23B | 3.20% |
| 2015 | $1.20B | -7.71% |
| 2014 | $1.30B | 15.02% |
| 2013 | $1.13B | 19.33% |
| 2012 | $943.78M | 16.57% |
| 2011 | $809.60M | 32.72% |
| 2010 | $610.02M | 29.33% |
| 2009 | $471.69M | 23.71% |
| 2008 | $381.28M | 38.09% |
| 2007 | $276.12M | 0.00% |
Venituri pentru companii similare sau concurente
| Companie | Venituri | Diferență de venituri | Țara |
|---|---|---|---|
| $12.62B | 361.49% |
US
|
|
| $2.23B | -18.55% |
US
|
|
| $15.74B | 475.55% |
AU
|
|
| $10.11B | 269.61% |
BE
|
|
| $6.02B | 120.11% |
NL
|
